EC Number |
Inhibitors |
Structure |
---|
2.3.1.147 | (3S,4R)-[4-(Isobutenyloxy)-3-triphenylmethylamino]azetitin-2-one |
i.e. SB 216754 |
|
2.3.1.147 | 1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine |
- |
|
2.3.1.147 | 1-[2-[3-(4-Chloro-3-trifluoromethylphenyl)ureido]-4-trifluoromethyl phenoxy]-4,5-dichlorobenzene sulfonic acid |
i.e. SK&F 45905 |
|
2.3.1.147 | 4-methoxybenzyl(3S,4R)-6-bromo-6-[(1-methyl-1,2,3-triazol-4-yl)-hydroxymethyl]penicillanate |
i.e. SB 212047 |
|
2.3.1.147 | Diethyl 7-(1,4,5-triphenyl imidazol-2-yloxy)heptane phosphonate |
SK&F 98628 |
|
2.3.1.147 | Diethyl 7-(3,4,5-triphenyl-2-oxo-2,3-dihydro-imidazol-1-yl)heptane-phosphonate |
i.e. SK&F 98625 |
|
2.3.1.147 | diethyl dicarbonate |
- |
|
2.3.1.147 | more |
inhibition of the enzyme attenuates the proliferation of breast cancer cell lines, intracellular level and distribution of free or triglyceride arachidonic acid, or an oxidized metabolite thereof, and blockage of remodeling are responsible for the effect, overview |
|
2.3.1.147 | N-tosyl-L-phenylalanine chloromethyl ketone |
- |
|
2.3.1.147 | NS-398 |
enzyme inhibition in cancer cell has an anti-carcinogenic effect and induces accumulation of unesterified arachidonic acid |
|